| First siderophore cephalosporin. |
| Excellent in vitro activity; stable vs all Ambler classes of β-lactamases (including metallo-β-lactamases). |
| Noninferior efficacy to carbapenems for cUTI and nosocomial infections; comparable efficacy to BAT in serious CR infections. |
| Good tolerability and safety profile. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.